Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Shares Outstanding (Diluted Average): 2010-2025

Historic Shares Outstanding (Diluted Average) for Sunshine Biopharma (SBFM) over the last 3 years, with Mar 2025 value amounting to $2.7 million.

  • Sunshine Biopharma's Shares Outstanding (Diluted Average) rose 321.53% to $2.7 million in Q1 2025 from the same period last year, while for Mar 2025 it was $2.7 million, marking a year-over-year increase of 321.53%. This contributed to the annual value of $701,749 for FY2024, which is 5371.73% up from last year.
  • According to the latest figures from Q1 2025, Sunshine Biopharma's Shares Outstanding (Diluted Average) is $2.7 million, which was up 285.22% from $701,749 recorded in Q4 2024.
  • Sunshine Biopharma's Shares Outstanding (Diluted Average)'s 5-year high stood at $25.7 million during Q3 2023, with a 5-year trough of $12,825 in Q4 2023.
  • In the last 3 years, Sunshine Biopharma's Shares Outstanding (Diluted Average) had a median value of $701,749 in 2024 and averaged $7.9 million.
  • Per our database at Business Quant, Sunshine Biopharma's Shares Outstanding (Diluted Average) tumbled by 99.92% in 2023 and then spiked by 5,371.73% in 2024.
  • Sunshine Biopharma's Shares Outstanding (Diluted Average) (Quarterly) stood at $2.6 million in 2021, then surged by 481.18% to $15.2 million in 2022, then plummeted by 99.92% to $12,825 in 2023, then surged by 5,371.73% to $701,749 in 2024, then skyrocketed by 321.53% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q1 2025, $701,749 for Q4 2024, and $641,310 during Q1 2024.